Literature DB >> 16631947

Treatment of primary cutaneous CD30+ anaplastic large cell lymphoma with intralesional methotrexate.

Jonathan E Blume, Howard L Stoll, Richard T Cheney.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16631947     DOI： 10.1016/j.jaad.2005.11.1037

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  3 in total

Review 1.  EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Authors:  Werner Kempf; Katrin Pfaltz; Maarten H Vermeer; Antonio Cozzio; Pablo L Ortiz-Romero; Martine Bagot; Elise Olsen; Youn H Kim; Reinhard Dummer; Nicola Pimpinelli; Sean Whittaker; Emmilia Hodak; Lorenzo Cerroni; Emilio Berti; Steve Horwitz; H Miles Prince; Joan Guitart; Teresa Estrach; José A Sanches; Madeleine Duvic; Annamari Ranki; Brigitte Dreno; Sonja Ostheeren-Michaelis; Robert Knobler; Gary Wood; Rein Willemze
Journal:  Blood       Date:  2011-08-12       Impact factor: 22.113

2.  Primary cutaneous anaplastic large cell lymphoma arising from lymphomatoid papulosis, responding to low dose methotrexate.

Authors:  As Nandini; Venkatram Mysore; S Sacchidanand; Suresh Chandra
Journal:  J Cutan Aesthet Surg       Date:  2009-07

3.  Intramatricial methotrexate for treatment of resistant acrodermatitis continua of Hallopeau: An alternative in COVID-19.

Authors:  Anuradha Jindal; Sandhiya Ramesh; Malcom Noronha; Kantilatha Pai; Sathish Pai
Journal:  Dermatol Ther       Date:  2020-07-02       Impact factor: 3.858
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.